Pristyn Care Enters Bangladesh’s Healthcare Market With Rs 100 Crore Investment1 min read

Pristyn Care, an Indian healthcare delivery startup, has reportedly announced its entry into Bangladesh’s healthcare market with an investment of Rs 100 crore over the next two years. The company, which provides advanced secondary care surgeries through its network of partner hospitals and clinics, aims to set up five patient care centers in Dhaka and Chattogram by March 2024.

Pristyn Care Co-Founder Harsimarbir Singh said in a statement that the company is committed to the growth of healthcare in Bangladesh, which is expected to reach $14 billion by the end of 2023. “Over the next two years, we will invest Rs 100 crore to establish a robust healthcare infrastructure,” he also added.
The investment will be used to set up patient care centers, where patients can consult with Pristyn Care’s in-house super-specialty surgeons and get access to diagnostic tests, insurance assistance, and post-operative care. The company claims to have over 400-plus surgeons across various specialties such as urology, gynecology, ENT, general surgery, and vascular surgery.

Read More: Exports Of Bangladesh Set A Record Of $4.59 Billion In July 2023, Bolstering Foreign Exchange Reserves.

The company said it plans to hire 200 employees across various departments such as operations, sales, marketing, and technology as part of its expansion plans in Bangladesh. It also said it will collaborate with local hospitals and doctors to provide quality healthcare services to the patients.

Pristyn Care, which was founded in 2018, has raised over $177 million in funding so far from investors such as Sequoia Capital India, Hummingbird Ventures, Tiger Global Management, and Epiq Capital.

For more updates, be with Markedium.

Get real time updates directly on you device, subscribe now.

You might also like
Notify of

Inline Feedbacks
View all comments
Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Would love your thoughts, please comment.x


Join our mailing list to receive the latest news and updates from Markedium!

You have Successfully Subscribed!